eXoZymes, Inc.
eXoZymes, Inc. (EXOZ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
exoz · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for eXoZymes, Inc. (EXOZ) measures how much investors pay for each dollar of the company's trailing earnings. EXOZ's current PE ratio of N/A is calculated by dividing its stock price of $8.62 by its TTM earnings per share of -$1.14.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
eXoZymes, Inc.You EXOZ | $73M | N/A | — | -$1.14 |
 Anebulo Pharmaceuticals, Inc. ANEB | $15M | N/A | — | -$0.25 |
 Atossa Therapeutics, Inc. ATOS | $39M | N/A | — | -$4.04 |
 Cognition Therapeutics, Inc. CGTX | $89M | N/A | — | -$0.32 |
 Estrella Immunopharma, Inc. ESLA | $49M | N/A | — | -$0.35 |
 Greenwich LifeSciences, Inc. GLSI | $318M | N/A | — | -$1.43 |
 Oncolytics Biotech Inc. ONCY | $84M | N/A | — | -$0.41 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.09 | — | |
2024-12-31 FY2024 | — | $-0.72 | — | |
2023-12-31 FY2023 | — | $-0.25 | — | |
2022-12-31 FY2022 | — | $-0.17 | — | |
2021-12-31 FY2021 | — | $-0.15 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for eXoZymes, Inc. (EXOZ) measures how much investors pay for each dollar of the company's trailing earnings. EXOZ's current PE ratio of N/A is calculated by dividing its stock price of $8.62 by its TTM earnings per share of -$1.14.
Frequently asked questions
EXOZ pe ratio · 6 questionsEXOZ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $8.62 and TTM EPS of -$1.14. Data sourced from Financial Modeling Prep via EXOZ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · eXoZymes, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09